Issue |
Vet. Res.
Volume 31, Number 1, January-February 2000
|
|
---|---|---|
Page(s) | 132 - 133 | |
DOI | https://doi.org/10.1051/vetres:2000062 | |
How to cite this article | Vet. Res. (2000) 132-133 |
DNA vaccine coding for glycoprotein B of PRV induces cytotoxic T cell responses in pigs against PRV
E.M.A. van Rooija, B.L. Haagmansb, H.L. Glansbeekb, Y.E. de Vissera, W. Boersmaa and A.T.J. Bianchiaa Departments of Mammalian Virology and Immunology, Institute for Animal Science and Health, ID-DLO, Lelystad, The Netherlands
b Virology Unit, Department of Infectious Diseases and Immunology, Veterinary Faculty, Utrecht University, Utrecht, The Netherlands
Abstract -
Vaccination based on naked DNA is regarded as an alternative to
conventional vaccines because it combines the efficacy of attenuated vaccines
with the biological safety of inactivated vaccines. Recently, we showed that
vaccination with
a cocktail of naked DNA coding for the immunorelevant glycoprotein B (gB),
gC and gD of pseudorabies virus (PRV) induced both antibody and cell-mediated immunity in
pigs and provided protection against challenge infection. To determine the
role of the different glycoproteins in the induction of protective immune responses against
PRV, we compared the efficacy of naked DNA coding for gB, gC and gD individually.
Groups of 10-12 weeks old SPF pigs were vaccinated three times with an interval of 4 weeks
between each vaccination. Pigs were vaccinated with
g of plasmid carrying
the gene coding for gB, gC or gD. Pigs vaccinated with
g sham plasmid served as the
sham-vaccinated control group. All pigs were vaccinated intradermally by syringe
needles. Six weeks after the third vaccination, all pigs were challenged intranasally with
105
plaque forming units of the virulent wild type strain NIA3 per animal to
assess protection. Animals were checked for humoral and cellular immune
responses at regular
intervals after vaccination. Virus excretion, body weight, fever and clinical
signs were assessed after challenge infection. Pigs vaccinated with gB-DNA or gC-DNA
developed moderate levels of neutralising antibodies whereas pigs vaccinated
with gD-DNA developed high levels of virus neutralising antibodies. In contrast, pigs
vaccinated with gB-DNA developed strong lymphoproliferation (LPT) responses
whereas pigs vaccinated with gC-DNA or gD-DNA developed weak LPT responses.
In addition, only
pigs vaccinated with gB-DNA developed clear cytotoxic T cell responses,
resulting in specific lysis of up to 50%. Both CD6
+
and CD6
- T lymphocytes were involved in
the cytolytic activity. All pigs vaccinated with gB-DNA or gD-DNA survived
challenge infection whereas one out of six pigs vaccinated with gC-DNA and two out of six
sham vaccinated pigs died. Pigs vaccinated with gD-DNA excreted virus for a
significantly shorter period than pigs vaccinated with gB-DNA or gC-DNA. Pigs vaccinated with
gB-DNA, however, had lower levels of viral peak excretion than pigs
vaccinated with gC-DNA, gD-DNA or the sham vaccinated pigs. Based on the duration of fever
and clinical signs, pigs vaccinated with gD-DNA were protected the best,
followed by pigs vaccinated with naked DNA coding for gB. We have
demonstrated that gB is
important for the induction of cytolytic anti-PRV T cells and that gD is
important for the induction of virus neutralising antibodies. Both glycoproteins protect
against a challenge infection and form an attractive alternative for
future anti-PRV DNA vaccines.
Corresponding author: E.M.A. van Rooij Fax: (31) 320 238668;
e-mail: e.m.a.vanrooij@id.dlo.nl
© INRA, EDP Sciences 2000